Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bailing tablet plus dual long-acting bronchodilators in stable COPD (lung–kidney deficiency) with smoking subgroup analysis
ChiCTR2100050118Phase 4Not yet recruiting
- Sponsor
- Huzhou Hospital of Traditional Chinese Medicine
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bailing jiaonang in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Huzhou Hospital of Traditional Chinese Medicine. Primary endpoints: TCM syndrome integral and Lung function. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
bailing jiaonang
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2100050118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050118.